Top compounds associated with response to LAD1


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 4e-07
mRNA PD 153035 CTRPv2 pan-cancer AAC 0.25 7e-07
mRNA ibrutinib CTRPv2 pan-cancer AAC 0.25 9e-07
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 2e-06
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 5e-06
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 5e-06
mRNA GSK269962A GDSC1000 pan-cancer AAC -0.19 6e-06
mRNA AZD0530 CTRPv2 pan-cancer AAC 0.2 6e-06
mRNA 5-FU CTRPv2 pan-cancer AAC 0.18 9e-06
mRNA PD318088 CTRPv2 pan-cancer AAC 0.19 1e-05
Download CSV